This inventor holds 5 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Pre Holding, Inc., Hydrate, Inc., Pari Innovative Manufacturers, Inc.. Active years: 2009-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2016
Title: Kevin Grant Gowanlock: Innovator in Aerosol Medication Delivery Systems
Introduction
Kevin Grant Gowanlock is a prominent inventor based in London, Canada. He has made significant contributions to the field of medical devices, specifically focusing on enhancing the delivery of aerosolized medications. With a total of five patents to his name, Gowanlock's innovations are paving the way for more effective asthma and respiratory treatment solutions.
Latest Patents
Among his latest inventions is the aerosol medication inhalation system. This apparatus is designed to work in conjunction with metered dose inhalers and features a novel valve system that enhances the delivery of aerosolized medicament to patients. Additionally, it incorporates a rotational flow generator to optimize medication delivery, ensuring that no valuable medication is lost either in the device or through ineffective delivery methods.
Career Highlights
Throughout his career, Kevin has been associated with notable companies such as Pre Holding, Inc. and Hydrate, Inc. His experiences in these organizations have played a crucial role in refining his innovative ideas and developing practical solutions for health-related challenges.
Collaborations
In his professional journey, Gowanlock has collaborated with talented individuals like Thomas Gallem and Robert Carlton Lynch. These partnerships have further enriched his work, bringing together diverse expertise to advance the projects in which they have been involved.
Conclusion
Kevin Grant Gowanlock continues to be an influential figure in the realm of medical device innovation. His dedication to improving patient outcomes through effective aerosol medication delivery systems exemplifies his commitment to healthcare advancement. As he continues to develop new technologies, the medical community eagerly anticipates his future contributions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile